Fertility and Sterility
Volume 94, Issue 3 , Pages 841-849, August 2010

The growth hormone–releasing hormone (GHRH) antagonist JV-1-36 inhibits proliferation and survival of human ectopic endometriotic stromal cells (ESCs) and the T HESC cell line

  • Marta Annunziata, Ph.D.

      Affiliations

    • Laboratory of Molecular and Cellular Endocrinology, Department of Internal Medicine, University of Turin, Turin, Italy
    • Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Turin, Turin, Italy
  • ,
  • Cristina Grande

      Affiliations

    • Laboratory of Molecular and Cellular Endocrinology, Department of Internal Medicine, University of Turin, Turin, Italy
    • Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Turin, Turin, Italy
  • ,
  • Francesca Scarlatti, Ph.D.

      Affiliations

    • Laboratory of Molecular and Cellular Endocrinology, Department of Internal Medicine, University of Turin, Turin, Italy
    • Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Turin, Turin, Italy
  • ,
  • Francesco Deltetto, M.D.

      Affiliations

    • Ginteam, Unit of Minimally Invasive Gynecology, Turin, Italy
  • ,
  • Elena Delpiano, M.D.

      Affiliations

    • Ginteam, Unit of Minimally Invasive Gynecology, Turin, Italy
  • ,
  • Marco Camanni, M.D.

      Affiliations

    • Ginteam, Unit of Minimally Invasive Gynecology, Turin, Italy
  • ,
  • Ezio Ghigo, M.D.

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Turin, Turin, Italy
  • ,
  • Riccarda Granata, Ph.D.

      Affiliations

    • Laboratory of Molecular and Cellular Endocrinology, Department of Internal Medicine, University of Turin, Turin, Italy
    • Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Turin, Turin, Italy
    • Corresponding Author InformationReprint requests: Riccarda Granata, Ph.D., Laboratory of Molecular and Cellular Endocrinology, Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Turin, Corso Dogliotti 14, 10126 Turin, Italy (FAX: (+39) 011 664 74 21).

Received 8 January 2009; received in revised form 24 March 2009; accepted 26 March 2009. published online 12 June 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 M.A. has nothing to disclose. C.G. has nothing to disclose. F.S. has nothing to disclose. F.D. has nothing to disclose. E.D. has nothing to disclose. M.C. has nothing to disclose. E.G. has nothing to disclose. R.G. has nothing to disclose.

 Supported by grants from the Regione Piemonte (2006 and 2008 to E.G.; 2008 to R.G.) and the University of Turin (2006 to E.G; 2007 and 2008 to E.G. and R.G.) and by Ginteam (Turin, Italy).

PII: S0015-0282(09)00763-8

doi:10.1016/j.fertnstert.2009.03.093

Fertility and Sterility
Volume 94, Issue 3 , Pages 841-849, August 2010